Thomas Lendvay
Thomas Lendvay is Co-Founder and Chief Executive Officer at Tend. He is Co-Founder and Chief Medical Officer at Amend Pet and Co-Founder and Chief Medical Officer at Singletto. He holds the role of Seattle Children's Hospital at Seattle Children's. He was Co-founder and Chief Medical Officer at C-SATS and is Co-Founder and Chief Medical Officer at Tend-Health. He is also Full Professor at UW Medicine.
Seattle Startup Singletto Launches FDA-Approved Virus-Killing Masks on Amazon Following $10M Funding and DARPA Support
Seattle startup Singletto, with $10 million in funding and support from DARPA, has launched FDA-approved virus-neutralizing face masks on Amazon using its Oxafence Active Protection technology that kills 99.9% of certain viruses. The masks are the only FDA-cleared products in the U.S. that inactivate tested viruses and may have applications in healthcare and national security.
Seattle Startup Singletto Gains FDA Approval for Virus-Killing Oxafence Surgical Masks
Seattle startup Singletto received FDA approval for its Oxafence technology, a methylene blue-treated surgical mask that kills 99.9% of certain viruses within five minutes. The masks are already in use in New Zealand and represent a significant advancement over traditional masks by actively inactivating pathogens.
MicrobiomX raises $1M pre-seed to commercialize stool collection, processing and capsule-encapsulation device
Seattle startup MicrobiomX raised $1 million in a pre-seed round to develop a device that collects, processes and extrudes stool into capsules for clinical fecal microbiota transplantation and offers microbiome analysis services. The company, launched in 2020 from UW and Seattle Children’s Hospital research after a $50,000 CoMotion grant, aims to simplify messy current stool-processing methods used for FMT and autologous FMT.
Organizations
See all 8Education
-
Temple University - Lewis Katz School of Medicine Doctor of Medicine (MD) · 1995–1999
-
Rice University Bachelor of Arts (B.A.), Biology and German · 1991–1995
Online
Questions about Thomas Lendvay
Who is Thomas Lendvay?
Thomas Lendvay is co-founder and chief executive officer at Tend, a role held since 2020. Thomas is also co-founder and chief medical officer at Amend Pet since 2022 and Singletto since 2020, and full professor at UW Medicine since 2004. Thomas was co-founder and chief medical officer at C-SATS from 2014 to 2018.
What is Thomas Lendvay known for?
Thomas Lendvay's work spans startup leadership, medical leadership and academia. GeekWire reported in December 2024 that Singletto, where Thomas is co-founder and chief medical officer, gained FDA approval for its virus-killing Oxafence surgical masks.
What has Thomas Lendvay been in the news for?
GeekWire reported in October 2025 that Singletto launched FDA-approved virus-killing masks on Amazon. GeekWire reported in December 2024 that Singletto gained FDA approval for its virus-killing Oxafence surgical masks.
Which organizations is Thomas Lendvay associated with?
Thomas Lendvay is associated with 8 organizations, including Tend as co-founder and chief executive officer since 2020, Amend Pet as co-founder and chief medical officer since 2022, and Singletto as co-founder and chief medical officer since 2020. Thomas is also full professor at UW Medicine since 2004 and was co-founder and chief medical officer at C-SATS from 2014 to 2018.
Where did Thomas Lendvay study?
Thomas Lendvay earned a Doctor of Medicine (MD) at Temple University - Lewis Katz School of Medicine from 1995 to 1999. Thomas studied Biology and German for a Bachelor of Arts (B.A.) at Rice University from 1991 to 1995.
Where is Thomas Lendvay based?
Thomas Lendvay is based in Seattle, Washington, United States.